New York State Common Retirement Fund
NMRA icon

New York State Common Retirement Fund’s Neumora Therapeutics NMRA Stock Holding History

New York State Common Retirement Fund’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,025
Closed -$26K – 3289
2025
Q1 		$26K Hold
26,025
– – ﹤0.01% 2937
2024
Q4 		$276K Hold
26,025
– – ﹤0.01% 2161
2024
Q3 		$344K Sell
26,025
-8,100
-24% -$94.5K ﹤0.01% 2088
2024
Q2 		$335K Buy
34,125
+27,131
+388% +$281K ﹤0.01% 2204
2024
Q1 		$96.2K Buy
6,994
+94
+1% +$1.52K ﹤0.01% 2756
2023
Q4 		$118K Buy
+6,900
New +$84.7K ﹤0.01% 2688

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

New York State Common Retirement Fund's NMRA Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Neumora Therapeutics (NMRA) in Q2 2025, closing a stake of 26,025 shares — an estimated $26K sold.

New York State Common Retirement Fund first reported a position in NMRA in Q4 2023 and held it in 6 quarters. The position peaked at $344K in Q3 2024. 98 funds tracked by Wall St. Rank hold NMRA as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Neumora Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 26,025 Neumora Therapeutics shares in Q2 2025, an estimated $26K.
  • New York State Common Retirement Fund first reported a position in Neumora Therapeutics in Q4 2023 and held it in 6 quarters.
  • New York State Common Retirement Fund's Neumora Therapeutics position peaked at $344K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.